Italy 2008 Conference
Return to Medical Education Page
Share this web-sites and these notes with your colleagues!
These notes were taken during the Florence International Course on Advances
in Cardiomyopathies – May 22/24, 2008. There is a wealth of information
and contacts to professionals in the field that are making a difference in this
"not so rare" condition.
Part 1 Contains 10 pages that include:
* Intro
* Table of Contents
* Guest Faculty Contact Information
* May 22 Pre-Opening Sessions
Advances in Cardiomyopathy Part 1
Share this web-sites and these notes with your colleagues!
These notes were taken during the Florence International Course on Advances
in Cardiomyopathies – May 22/24, 2008. There is a wealth of information
and contacts to professionals in the field that are making a difference in this
"not so rare" condition.
Part 1 Contains 10 pages that include:
* Intro
* Table of Contents
* Guest Faculty Contact Information
* May 22 Pre-Opening Sessions
Advances in Cardiomyopathy Part 1
Part 2 Contains 10 pages that includes:
* Official Opening
Session 1
* General principles: nomenclature, classification, mechanisms
* The contemporary classifications of cardiomyopathies
* Genetic basis of cardiomyopathies: an overview
* Molecular mechanisms of dysfunction and failure
* Contribution of pathology to the understanding of cardiomyopathies
* Role of endomyocardial biopsy in 2008
Session 2
* HCM diagnosis and clinical assessment
* Diagnostic criteria, differential diagnosis and clinical spectrum
* Cardiac involvement in Anderson Fabry disease
* Pathophysiology of symptoms and disease progression
* Echo verses MRI for clinical management
* Assessment of microvascular dysfunction and significance of ischemia
* Future applications of cardiac MRI imaging
Session 3
* HCM translational research: insights from basic science and clinical genetics
Advances in Cardiomyopathy Part 2
* Official Opening
Session 1
* General principles: nomenclature, classification, mechanisms
* The contemporary classifications of cardiomyopathies
* Genetic basis of cardiomyopathies: an overview
* Molecular mechanisms of dysfunction and failure
* Contribution of pathology to the understanding of cardiomyopathies
* Role of endomyocardial biopsy in 2008
Session 2
* HCM diagnosis and clinical assessment
* Diagnostic criteria, differential diagnosis and clinical spectrum
* Cardiac involvement in Anderson Fabry disease
* Pathophysiology of symptoms and disease progression
* Echo verses MRI for clinical management
* Assessment of microvascular dysfunction and significance of ischemia
* Future applications of cardiac MRI imaging
Session 3
* HCM translational research: insights from basic science and clinical genetics
Advances in Cardiomyopathy Part 2
Part 3 Contains 10 pages that includes:
* Lessons from mouse models
* Biophysical consequences of sarcomere gene mutations
* Old genes, new genes and correlations with phenotype
* Disease mechanisms in inherited DCM
Session 4
* HCM clinical management
* An overview of contemporary treatment options
* State-of-the-art management of atrial fibrillation and ventricular arrhythmias
* Prevention of systemic embolism: old and new drugs
* Round Table: How to relieve LVOT obstruction
* Lessons learned from a decade of alcohol septal ablation
* Lessons learned from four decades of surgical myectomy
Advances in Cardiomyopathy Part 3
* Lessons from mouse models
* Biophysical consequences of sarcomere gene mutations
* Old genes, new genes and correlations with phenotype
* Disease mechanisms in inherited DCM
Session 4
* HCM clinical management
* An overview of contemporary treatment options
* State-of-the-art management of atrial fibrillation and ventricular arrhythmias
* Prevention of systemic embolism: old and new drugs
* Round Table: How to relieve LVOT obstruction
* Lessons learned from a decade of alcohol septal ablation
* Lessons learned from four decades of surgical myectomy
Advances in Cardiomyopathy Part 3
Part 4 Contains 10 pages that include:
* Restorative tailored surgical approach
* Panel discussion
Session 5
* LV dysfunction, dilated Cardiomyopathy and ARVC
* Genetic screening in the clinical setting: state-of-the-art
* Update on ARVC: morphological spectrum and outcome
* The Italian perspective
* Sudden death prevention: ICD patient selection and risk/benefit ratio
* In HCM
* In DCM and ARVC
* Clinical management of ARVC
* Restrictive cardiomyopathies and children
* Cardiomyopathies in children including LV non compaction
* Differential diagnosis and management of cardiac amyloidoses
* Tropical neglected cardiomyopathies
Session 7
* Round Table: How to implement education and translational research in cardiomyopathies
Session 8
Advances in Cardiomyopathy Part 4
* Restorative tailored surgical approach
* Panel discussion
Session 5
* LV dysfunction, dilated Cardiomyopathy and ARVC
* Genetic screening in the clinical setting: state-of-the-art
* Update on ARVC: morphological spectrum and outcome
* The Italian perspective
* Sudden death prevention: ICD patient selection and risk/benefit ratio
* In HCM
* In DCM and ARVC
* Clinical management of ARVC
* Restrictive cardiomyopathies and children
* Cardiomyopathies in children including LV non compaction
* Differential diagnosis and management of cardiac amyloidoses
* Tropical neglected cardiomyopathies
Session 7
* Round Table: How to implement education and translational research in cardiomyopathies
Session 8
Advances in Cardiomyopathy Part 4
Part 5 Containes 10 pages that contain:
* In athletes and in the young
* Prevention and management of ICD-related complications
* Discussion
* Young Investigator Awards
Session 9
* New advances in CRT, LVAD, heart transpland and regenerative medicine
* New directions for cardiomyopathies: what's next
* Patient selection and expected benefits of cardiac resynchronization therapy
* Gene therapy and stem cells: dream or reality
* Lecture: New advances in reverse remodeling and regenerative medicine
* Conclusion and final remarks
* Poster Session: P1 through P14
Advances in Cardiomyopathy Part 5
* In athletes and in the young
* Prevention and management of ICD-related complications
* Discussion
* Young Investigator Awards
Session 9
* New advances in CRT, LVAD, heart transpland and regenerative medicine
* New directions for cardiomyopathies: what's next
* Patient selection and expected benefits of cardiac resynchronization therapy
* Gene therapy and stem cells: dream or reality
* Lecture: New advances in reverse remodeling and regenerative medicine
* Conclusion and final remarks
* Poster Session: P1 through P14
Advances in Cardiomyopathy Part 5
Part 6 Contains 4 pages that include:
* Poster Session: P14 through P26
* Poster Session: P27 through P38
* Poster Session: P39 through P51
* Poster Session: P48 through P60
Advances in Cardiomyopathy Part 6
* Poster Session: P14 through P26
* Poster Session: P27 through P38
* Poster Session: P39 through P51
* Poster Session: P48 through P60
Advances in Cardiomyopathy Part 6
